[HTML][HTML] Co-expression of CD44/MyD88 is a poor prognostic factor in advanced epithelial ovarian cancer
Y Zhu, H Zhang, G Zhang, Y Shi… - Annals of Translational …, 2019 - ncbi.nlm.nih.gov
Background Cluster of differentiation 44 (CD44)/myeloid differentiation factor 88 (MyD88) is
the molecular characterization of EOC stem cells. An important characteristic of …
the molecular characterization of EOC stem cells. An important characteristic of …
[HTML][HTML] Identification of prognosis-related hub genes of ovarian cancer through bioinformatics analyses and experimental verification
Z Yu, L Ouyang - Medicine, 2022 - journals.lww.com
Ovarian cancer (OC) is a lethal and highly prevalent disease in women worldwide. The
disease is often diagnosed in late stages, which leads to its rapid progression and low …
disease is often diagnosed in late stages, which leads to its rapid progression and low …
[HTML][HTML] Molecular biomarkers for the early detection of ovarian cancer
R Zhang, MKY Siu, HYS Ngan, KKL Chan - International Journal of …, 2022 - mdpi.com
Ovarian cancer is the deadliest gynecological cancer, leading to over 152,000 deaths each
year. A late diagnosis is the primary factor causing a poor prognosis of ovarian cancer and …
year. A late diagnosis is the primary factor causing a poor prognosis of ovarian cancer and …
RETRACTED ARTICLE: Targeting of KDM5A by miR-421 in Human Ovarian Cancer Suppresses the Progression of Ovarian Cancer Cells
F Ren, C Shrestha, H Shi, F Sun, M Zhang… - OncoTargets and …, 2020 - Taylor & Francis
Purpose The retinoblastoma binding protein RBP2 (KDM5A) is a histone demethylase that
promotes cell growth in many human cancers. A series of functional experiments were …
promotes cell growth in many human cancers. A series of functional experiments were …
Combined serum DKK3 and circulating CD133 cells as prognostic biomarkers for ovarian cancer patients
XC Nie, F He, C Lan, JM Niu, P Xia - OncoTargets and therapy, 2021 - Taylor & Francis
Introduction Ovarian cancer (OV) can seriously endanger women's physical and mental
health. Serum DKK3 has been used for the diagnosis and prognosis of patients with ovarian …
health. Serum DKK3 has been used for the diagnosis and prognosis of patients with ovarian …
[HTML][HTML] LINC00525 enhances ZNF460-regulated CD24 expression through the sponge miR-125a-5p to promote malignant progression of breast cancer
J Wang, J Shi, Y Xiang, ZW Wang, FF Qi, ZY Li… - Journal of Cancer …, 2024 - Springer
Introduction CD24 is a highly glycosylated glycosylphosphatidylinositol anchored
membrane protein that plays an important role in tumor progression. The aim of this study …
membrane protein that plays an important role in tumor progression. The aim of this study …
[HTML][HTML] Free CA125 promotes ovarian cancer cell migration and tumor metastasis by binding Mesothelin to reduce DKK1 expression and activate the SGK3/FOXO3 …
Q Huo, C Xu, Y Shao, Q Yu, L Huang… - International Journal of …, 2021 - ncbi.nlm.nih.gov
Objective: CA125/MUC16 is an O-glycosylated protein that is expressed on the surfaces of
ovarian epithelial cells. This molecule is a widely used tumor-associated marker for …
ovarian epithelial cells. This molecule is a widely used tumor-associated marker for …
[HTML][HTML] Promotion of ovarian cancer cell invasion, migration and colony formation by the miR‑21/Wnt/CD44v6 pathway
Y Wang, X Yang, M Yuan, S Xian… - Oncology …, 2019 - spandidos-publications.com
Ovarian cancer (OC) has the highest mortality rate among female malignant tumors, and OC
commonly relapses and metastasizes. The mechanisms underlying the occurrence and …
commonly relapses and metastasizes. The mechanisms underlying the occurrence and …
[HTML][HTML] CT-based radiomics predicts CD38 expression and indirectly reflects clinical prognosis in epithelial ovarian cancer
Y Yao, H Zhang, H Liu, C Teng, X Che, W Bian… - Heliyon, 2024 - cell.com
Background Cluster of differentiation 38 (CD38) has been found to be highly expressed in
various solid tumours, and its expression level may be associated with patient prognosis …
various solid tumours, and its expression level may be associated with patient prognosis …
F-box and leucine-rich repeat protein 20 (FBXL20), negatively regulated by microRNA (miR)-195-5p, accelerates the malignant progression of ovarian cancer
D Wu, C Liu, L Hong - Molecular Biotechnology, 2021 - Springer
Ovarian cancer (OC) is one of the most common cancers among women, characterized by
various histological subtypes. Here, we aimed to investigate the biological function of F-box …
various histological subtypes. Here, we aimed to investigate the biological function of F-box …